CTMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
CytomX Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.34+0.06 (+2.63%)
Close on Oct 19, 2026
- Market cap
- $512.32M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of CytomX Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 22, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 27, 2025 | May 28, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2025 | Mar 6, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 6, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2025 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2025 | Feb 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2025 | Jan 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2024 | Jun 17, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 17, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 15, 2024 | Apr 4, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2024 | Mar 22, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2024 | Mar 11, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 11, 2024 | SEC EDGAR |